ReviewMolecular therapy. Oncology2024

Genetic dysregulation of EP300 in cancers in light of cancer epigenome control - targeting of p300-proficient and -deficient cancers.

Karolina Gronkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.